Abstract
Purpose:
The purpose of this study was to investigate whether laser irradiation, used to activate an adhesive for sealing penetrating corneal incisions, causes any ophthalmoscopically or histologically visible retinal changes.
Methods:
Baseline fundus assessment was conducted prior to laser irradiation of eyes of pigmented Dutch Belted rabbits. Treatment group was 18 eyes with the corneal adhesive activated in situ by a near infrared laser (125 mW for 45 seconds). The positive control group was 18 eyes, each irradiated for 60 seconds at 375, 500, 625, and 750 mW at different retinal locations. Unexposed regions of the retina were used as negative internal control. Ophthalmoscopic assessment was conducted immediately after laser exposure and prior to euthanasia. Retinas were histologically assessed at 0, 3, 72, and 168 hours after treatment.
Results:
No ophthalmoscopically or histologically visible retinal changes were observed in the treatment group immediately, nor up to 168 hours after laser irradiation. In the positive control group, the incidences of ophthalmoscopically visible retinal lesions increased with irradiation power: 5.6% at 375 mW, 16.7% at 500 mW, 44.4% at 625 mW, and 50% at 750 mW. Histologically, retinal damage was observed as coagulative necrosis to all layers of the neural retina, including the retinal pigment epithelium.
Conclusions:
The laser irradiation process used in the corneal adhesive technology did not cause any ophthalmoscopically or histologically visible retinal changes in the in vivo pigmented rabbit model. Prolonged exposure with this laser and at higher power can cause coagulative necrosis to the retina.
Translational Relevance:
The corneal adhesive can be applied in humans without causing laser retinal damage.
A total of 18 pigmented Dutch Belted rabbits were bred for this study (Piper's farm, Cowra, New South Wales, Australia). Rabbits were of mixed genders, used at 5 months old to ensure head maturity, weighing between 1.26 and 1.70 kg at the time of the procedure.
14 Rabbits were acclimatized in our facility for at least 1 week prior to any procedure, and had unlimited access to chow and water. All animal procedures adhered to the ARVO statement for the Use of Animals in Ophthalmic and Vision Research. Institutional animal ethics committee approval (University of Sydney AEC 2019/1607) was obtained prior to any procedures. In accordance with the reduction principle for ethical use of animals, the right eyes (
n = 18) were used for delayed timepoints of 3, 72, and 168 hours, whereas the left eyes (
n = 18) were used for timepoint 0 hours prior to euthanasia.
All procedures were performed aseptically under an operating microscope. Sterile drapes, gloves, and surgical gowns were used. A sterile wire eyelid speculum was used to open the palpebral fissure. Prior to the procedure, topical oxybuprocaine hydrochloride (0.4%), tropicamide sulphate (1%), phenylephrine hydrochloride (2.5%), and chloramphenicol (0.5%) were instilled over the corneal surface and into the conjunctival fornix. All eyedrops were single-use Minims (Bausch & Lomb).
General anesthesia was provided by a specialist team of veterinarians. Premedication was a combined intramuscular injection (IM) of methadone (1 mg/kg), dexmedetomidine (50 mcg/kg) and midazolam (0.5 mg/kg). The induction agent used was intravenous (IV) propofol (6 mg/kg), and IV rocuronium (10 mcg/kg) was used as a paralytic agent to ensure no eye movements. Maintenance of anesthesia was by inhalational isoflurane (1.5 to 3.0%). Atipamezole (0.5 mg) was given IM as a sedation reversal agent. A topical buprenorphine (25 mcg/hr) patch was applied to all rabbits for analgesia. Rabbits’ welfare was monitored hourly until full recovery from anesthesia, then twice daily for the first 3 days, and daily thereafter until the planned end point. Supplemental anesthetic/analgesic drugs were used at the discretion of the veterinary anesthetist for managing animal welfare.
A direct ophthalmoscope (oDocs nun, oDocs Eye Care, New Zealand) with smartphone (iPhone XR, Apple Inc.) attachment capability, was used to assess the fundus of each eye. The fundus was assessed preprocedure (baseline), immediately after each laser exposure (0 hour), and prior to euthanasia at each planned timepoint. A video recording was created for each fundoscopic assessment, and the captured images were screened by frames for visible laser lesions.
The laser parameters required to activate an adhesive designed to seal penetrating corneal incisions, did not result in any ophthalmoscopically or histologically visible retinal lesions immediately after exposure, and after 168 hours in the pigmented Dutch Belted in vivo rabbit model. Based on this, it is unlikely to cause retinal changes in humans. This laser can cause retinal damage to all layers of the neural retina, including the RPE, when it was operated stationarily at higher power.
Funded by National Health and Medical Research Council (NHMRC) project Grant (APP1067749 to Foster and Watson). Stephanie Watson is a Sydney Medical School Foundation Fellow.
Disclosure: J. Tan, None; L.J.R. Foster, None; F.J. Lovicu, None; S.L. Watson, None